The state government will share best practices for monitoring the use of unregulated chemicals in drug manufacturing, Narayan said after meeting with Rahul Gupta, director of White House Office of National Drug Control Policy (ONDCP), on Monday.
Collaborative engagements in the areas of enforcement, regulatory frameworks, transparency through effective IT systems, and building of robust frameworks for the growth of the pharmaceutical industry were discussed at the meeting.
This comes in the backdrop of firms globally pursuing ‘China+1’ strategy to reduce dependence on China for drugs and other products for the US and other markets.
“India and the US are already working on bolstering the India-US counter-narcotics agreement as India assumes G20 presidency from December this year,” Narayan said after the talks.
The Karnataka government is exploring partnerships with the US to continue to strengthen this dialogue, he said. “We look forward to interacting (further) with the White House and delegates from the US soon,” said Narayan who is also the minister for science and technology, higher education, skill development, entrepreneurship, and livelihood.
Discover the stories of your interest
As per the New Education Policy (NEP), the central government in 2021 had unveiled its ambitious ‘Twinning programme’ to internationalise higher education.
Cooperation in student exchange programmes, educational twinning programmes, curriculum building, upskilling, and job growth in leading edge programmes in healthcare, biotech, IT and data security were also discussed in detail during the minister’s meeting with the US official.
A 2021 World Drug Report released by the United Nations Office on Drugs and Crime (UNODC) indicated that more than 36 million people have suffered from substance use disorders (SUD).
According to Global Data’s Clinical Trial Database, nearly 80% of clinical trials are being sponsored by academic institutions. The pharmaceutical industry is lagging behind in the clinical arena of addiction treatments.
